The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes

Annual Review of Nutrition

Volumn 31, Issue , 2011, Pages 203-234

  Madden, Jacqueline ^a   Williams, Christine M ^a   Calder, Philip C ^b   Lietz, Georg ^c   Miles, Elizabeth A ^b   Cordell, Heather ^c   Mathers, John C ^c   Minihane, Anne Marie ^a,d  

^a UNIVERSITY OF READING   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Cardiovascular; DHA; EPA; Fish oils; Genotype; Long chain n 3 PUFA

Indexed keywords

ACYL COENZYME A DESATURASE 1; APOLIPOPROTEIN E; ARACHIDONIC ACID; CD44V ANTIGEN; DOCOSAHEXAENOIC ACID; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID BINDING PROTEIN 2; FISH OIL; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN; HLA DR ANTIGEN; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERCELLULAR ADHESION MOLECULE 1; LEPTIN RECEPTOR; LEUKOTRIENE B3; LEUKOTRIENE B4; LINOLENIC ACID; LINOLEOYL COENZYME A DESATURASE; LOW DENSITY LIPOPROTEIN; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN E2; PROSTAGLANDIN E3; TRIACYLGLYCEROL; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CD25+ T LYMPHOCYTE; CELL TRANSPORT; CHROMOSOME 10Q; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 18Q; CHROMOSOME 19P; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 21Q; CHROMOSOME 22Q; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 4Q; CHROMOSOME 5P; CHROMOSOME 6Q; CHROMOSOME 7Q; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DIET THERAPY; EXON; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; FATTY ACID TRANSPORT; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOSE TOLERANCE TEST; GRANULOCYTE; HEART INFARCTION; HEART PROTECTION; HEMOSTASIS; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INCIDENCE; INFLAMMATION; INTRAVENOUS GLUCOSE TOLERANCE TEST; INTRON; ISCHEMIC HEART DISEASE; LYMPHOCYTE; MONOCYTE; NEUTROPHIL; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; PULSE WAVE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOLOGICAL MARKERS; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; FATTY ACIDS, OMEGA-3; FISH OILS; GENETIC ASSOCIATION STUDIES; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 79960540926     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-010411-095239     Document Type: Article

References (128)

1. Agren JJ, Vidgren HM, Valve RS, Laakso M, Uusitupa MI. 2001. Postprandial responses of individual fatty acids in subjects homozygous for the threonine-or alanine-encoding allele in codon 54 of the intestinal fatty acid binding protein 2 gene. Am. J. Clin. Nutr. 73:31-35 (Pubitemid 32016812)
2. Ahnve S. 1991. Is QT interval prolongation a strong or weak predictor for cardiac death? Circulation 84:1862-65
3. Almeida JC, Gross JL, Canani LH, Zelmanovitz T, Perassolo MS, Azevedo MJ. 2010. The Ala54Thr polymorphism of the FABP2 gene influences the postprandial fatty acids in patients with type 2 diabetes. J. Clin. Endocrinol. Metab. 95:3909-17
4. Aulchenko YS, Ripatti S, Lindqvist I, Boomsma D, Heid IM, et al. 2009. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Nat. Genet. 41:47-55
5. Baier LJ, Bogardus C, Sacchettini JC. 1996. A polymorphism in the human intestinal fatty acid binding protein alters fatty acid transport across Caco-2 cells. J. Biol. Chem. 271:10892-96 (Pubitemid 26145828)
6. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, et al. 1 995. An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J. Clin. Invest. 95:1281-87
7. Balk EM, Lichtenstein AH, Chung M, Kupelnick B, Chew P, Lau J. 2006. Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review. Atherosclerosis 184:237-46 (Pubitemid 43049706)
8. Baylin A, Ruiz-Narvaez E, Kraft P, Campos H. 2007. alpha-Linolenic acid, Delta6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction. Am. J. Clin. Nutr. 85(2):554-60 (Pubitemid 46220962)
9. Bouma G, Crusius JB, Oudkerk Pool M, Kolkman JJ, von Blomberg BM, et al. 1996. Secretion of tumour necrosis factor alpha and lymphotoxin alpha in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand. J. Immunol. 43:456-63 (Pubitemid 26104933)
10. BulpittCJ. 1988. Responders and non-responders to antihypertensive treatment. Drugs 35(Suppl. 6):142-46
11. Burdge GC. 2006. Metabolism of alpha-linolenic acid in humans. Prostaglandins Leukot. Essent. Fatty Acids 75:161-68
12. Burr ML, Fehily AM,Gilbert JF, Rogers S, Holliday RM, et al. 1989. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2(8666):757-61 (Pubitemid 19234807)
13. Calder PC. 2006. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases.Am. J. Clin. Nutr. 83:1505-19S
14. Caron-Dorval D, Paquet P, Paradis AM, Rudkowska I, Lemieux S, et al. 2008. Effect of the PPAR-alpha L162V polymorphism on the cardiovascular disease risk factor in response to n-3 polyunsaturated fatty acids. J. Nutrigenet. Nutrigenomics 1(4):205-12 (Pubitemid 351873359)
15. Caslake MJ, Miles EA, Kofler BM, Lietz G, Curtis P, et al. 2008. Effect of sex and genotype on cardiovascular biomarker response to fish oils: the FINGEN Study. Am. J. Clin. Nutr. 88:618-29
16. Cianflone K, Paglialunga S, Roy C. 2008. Intestinally derived lipids: metabolic regulation and consequences-an overview. Atherosclerosis (Suppl. 9):63-68
17. Clarke SD. 2004. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol. 15(1):13-18 (Pubitemid 39118012)
18. Cooper A, Skinner J, Nherera L, Feder G, Ritchie G, et al. 2007. Clinical Guidelines and Evidence Review for Post Myocardial Infarction: Secondary Prevention in Primary and Secondary Care for Patients Following a Myocardial Infarction. London: Natl. Collab. Cent. Primary Care Royal Coll. Gen. Practitioners
19. Debril MB, Renaud JP, Fajas L, Auwerx J. 2001. The pleiotropic functions of peroxisome proliferatoractivated receptor gamma. J. Mol. Med. 79:30-47 (Pubitemid 32250021)
20. Deeb SS, Fajas L, Nemoto M, Pihlajam̈aki J, Mykk̈anen L, et al. 1998. A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat. Genet. 20:284-87 (Pubitemid 28507675)
21. DeMarzo AM, Platz EA, Sutcliffe S, Xu J, Gr̈onberg H, et al. 2007. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 7:256-69 (Pubitemid 46486616)
22. Drenos F, Whittaker JC, Humphries SE. 2007. The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk. Ann. Hum. Genet. 71:611-19 (Pubitemid 47087069)
23. Dwyer JH, Allayee H, Dwyer KM, Fan J, Wu H, et al. 2004. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N. Engl. J. Med. 350(1):29-37 (Pubitemid 38032181)
24. Eriksson P, Nilsson L, Karpe F, Hamsten A. 1998. Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia. Arterioscler. Thromb. Vasc. Biol. 18:20-26 (Pubitemid 28047594)
25. Flavell DM, Pineda Torra I, Jamshidi Y, Evans D, Diamond JR, et al. 2000. Variation in the PPARalpha gene is associated with altered function in vitro and plasma lipid concentrations in type II diabetic subjects. Diabetologia 43:673-80 (Pubitemid 30322086)
26. Fontaine-Bisson B, El-Sohemy A. 2008. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and plasma high-density lipoproteincholesterol concentrations in a population of young adults. J. Nutrigenet. Nutrigenomics 1(5):215-23
27. Fontaine-Bisson B, Wolever TM, Chiasson JL, Rabasa-Lhoret R, Maheux P, et al. 2007. Genetic polymorphisms of tumor necrosis factor-alpha modify the association between dietary polyunsaturated fatty acids and fasting HDL-cholesterol and apo A-I concentrations. Am. J. Clin. Nutr. 86(3):768-74 (Pubitemid 47435846)
28. Fontaine-Bisson B, Wolever TM,Connelly PW, Corey PN, El-Sohemy A. 2009. NF-kappaB-94Ins/Del ATTG polymorphism modifies the association between dietary polyunsaturated fatty acids and HDLcholesterol in two distinct populations. Atherosclerosis 204:465-70
29. Fradet V, Cheng I, Casey G, Witte JS. 2009. Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin. Cancer Res. 15(7):2559-66
30. Friedlander Y, Vatta M, Sotoodehnia N, Sinnreich R, Li H, et al. 2005. Possible association of the human KCNE1 (minK) gene and QT interval in healthy subjects: evidence from association and linkage analyses in Israeli families. Ann. Hum. Genet. 69(Pt. 6):645-56 (Pubitemid 41556319)
31. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FJ, Burrell MA. 2001. The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. Endocrinol. Metab. 280:E827-47 (Pubitemid 32553225)
32. Gissi Prevenzione Trial Group. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet 354(9177):447-55
33. Goldman DW, Pickett WC, Goetzl EJ. 1983. Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid. Biochem. Biophys. Res. Commun. 117:282-88 (Pubitemid 14216878)
34. Grimble RF, Howell WM, O'Reilly G, Turner SJ, Markovic O, et al. 2002. The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production. Am. J. Clin. Nutr. 76(2):454-59 (Pubitemid 34804072)
35. Guerreiro CS, Ferreira P, Tavares L, Santos PM, Neves M, et al. 2009. Fatty acids, IL6, and TNFalpha polymorphisms: an example of nutrigenetics in Crohn's disease. Am. J. Gastroenterol. 104(9):2241-49
36. Guillot N, Caillet E, Laville M, Calzada C, Lagarde M, V́ericel E. 2009. Increasing intakes of the long-chain omega-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men. FASEB J. 23:2909-16
37. Hamsten A, de Faire U,Walldius G, Dahĺen G, Szamosi A, et al. 1987. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2(8549):3-9 (Pubitemid 17083665)
38. Harris WS. 1997. N-3 fatty acids and serum lipoproteins: human studies. Am. J. Clin. Nutr. 65(Suppl.):1645-54S
39. Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ. 2008. Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. Atherosclerosis 197:12-24
40. Hartweg J, Perera R,Montori V, Dinneen S, Neil HA, Farmer A. 2008. Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus. Cochrane Database Syst. Rev. 23(1):CD003205
41. Hauser PS, Narayanaswami V, Ryan RO. 2011. Apolipoprotein E: from lipid transport to neurobiology. Prog. Lipid Res. 50(1):62-74
42. Hedelin M, Chang ET, Wiklund F, Bellocco R, Klint A, et al. 2007. Association of frequent consumption of fatty fish with prostate cancer risk ismodified by COX-2 polymorphism. Int. J. Cancer 120(2):398-405 (Pubitemid 44956853)
43. Helwig U, Rubin D, Klapper M, Li Y, Nothnagel M, et al. 2007. The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability. Metabolism 56:723-31 (Pubitemid 46734078)
44. Hickenbottom SJ, Follett JR, Lin Y, Dueker SR, Burri BJ, et al. 2002. Variability in conversion of betacarotene to vitamin A in men as measured by using a double-tracer study design. Am. J. Clin. Nutr. 75(5):900-7 (Pubitemid 34441259)
45. Hodson L, Skeaff CM, Fielding BA. 2008. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 47:348-80
46. Humphries SE, Talmud PJ,Hawe E, Bolla M, Day IN, Miller GJ. 2001. Apolipoprotein E4 and coronary heart disease in middle-aged men who smoke: a prospective study. Lancet 358:115-19 (Pubitemid 32709850)
47. Hyman LJ, Kincade RPW. 1993. CD44 and its interaction with extracellular matrix. Adv. Immunol. 54:271-335
48. Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA. 1990. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 87:1233-37
49. Jovinge S, Hamsten A, Tornvall P, Proudler A, Bavenholm P, et al. 1998. Evidence for a role of tumor necrosis factor alpha in disturbances of triglyceride and glucose metabolism predisposing to coronary heart disease. Metabolism 47:113-18 (Pubitemid 28086243)
50. Jump DB. 2008. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr. Opin. Lipidol. 19:242-47 (Pubitemid 351653561)
51. Khan S, Minihane AM,Talmud PJ,Wright JW, Murphy MC, et al. 2002. Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype. J. Lipid Res. 43(6):979-85 (Pubitemid 34602621)
52. Kris-Etherton PM, Harris WS, Appel LJ. 2003. Omega-3 fatty acids and cardiovascular disease: new recommendations from the American Heart Association. Arterioscler. Thromb. Vasc. Biol. 23:151-52 (Pubitemid 36231919)
53. Lai CQ, Corella D, Demissie S, Cupples LA, Adiconis X, et al. 2006. Dietary intake of n-6 fatty acids modulates effect of apolipoprotein A5 gene on plasma fasting triglycerides, remnant lipoprotein concentrations, and lipoprotein particle size: the Framingham Heart Study. Circulation 113(17):2062-70
54. Landmesser U, Hornig B, Drexler H. 2004. Endothelial function: a critical determinant in atherosclerosis? Circulation 109:1127-33
55. Langin D, Arner P. 2006. Importance of TNFalpha and neutral lipases in human adipose tissue lipolysis. Trends Endocrinol. Metab. 17:314-20 (Pubitemid 44419491)
56. Leaf A. 2007. Omega-3 fatty acids and prevention of arrhythmias. Curr. Opin. Lipidol. 18:31-34 (Pubitemid 46090234)
57. Lee TH, Mencia-Huerta JM, Shih C, Corey EJ, Lewis RA, Austen KF. 1984. Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J. Clin. Invest. 74:1922-33 (Pubitemid 15197332)
58. Leeson CP, Hingorani AD, Mullen MJ, Jeerooburkhan N, Kattenhorn M, et al. 2002. Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ. Res. 90(11):1153-58 (Pubitemid 34786899)
59. Leigh-Firbank EC, Minihane AM, Leake DS,Wright JW, Murphy MC, et al. 2002. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. Br. J. Nutr. 87:435-45 (Pubitemid 34575565)
60. Lewis RA, Austen KF, Soberman RJ. 1990. Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. N. Engl. J. Med. 323:645-55 (Pubitemid 20280195)
61. Li J, Wu X, Li X, Feng G, He L, Shi Y. 2010. The endothelial nitric oxide synthase gene is associated with coronary artery disease: a meta-analysis. Cardiology 116:271-78
62. Lindi V, Schwab U, Louheranta A, Laakso M, Vessby B, et al. 2003. Impact of the Pro12Ala polymorphism of the PPAR-gamma2 gene on serum triacylglycerol response to n-3 fatty acid supplementation. Mol. Genet. Metab. 79(1):52-60 (Pubitemid 36579441)
63. Lindi V, Schwab U, Louheranta A, Vessby B, Hermansen K, et al. 2008. The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity andLDLcholesterol: the KANWU Study. Nutr. Metab. Cardiovasc. Dis. 18(2):88-95 (Pubitemid 351282467)
64. Lindman AS, Pedersen JI, Hjerkinn EM, Arnesen H, VeierødMB, et al. 2004. The effects of long-term diet and omega-3 fatty acid supplementation on coagulation factor VII and serum phospholipids with special emphasis on the R353Q polymorphism of the FVII gene. Thromb. Haemost. 91(6):1097-104 (Pubitemid 38821265)
65. Madden J, Brunner A, Dastur ND, Tan RM, Nash GB, et al. 2007. Fish oil induced increase in walking distance, but not ankle brachial pressure index, in peripheral arterial disease is dependent on both body mass index and inflammatory genotype. Prostaglandins Leukot. Essent. Fatty Acids 76(6):331-40 (Pubitemid 47095273)
66. Madden J, Carrero JJ, Brunner A, Dastur N, Shearman CP, et al. 2008. Polymorphisms in the CD36 gene modulate the ability of fish oil supplements to lower fasting plasma triacyl glycerol and raise HDL cholesterol concentrations in healthy middle-aged men. Prostaglandins Leukot. Essent. Fatty Acids 78(6):327-35
67. Madden J, Shearman CP, Dunn RL, Dastur ND, Tan RM, et al. 2009. Altered monocyte CD44 expression in peripheral arterial disease is corrected by fish oil supplementation. Nutr. Metab. Cardiovasc. Dis. 19(4):247-52
68. Malerba G, Schaeffer L, Xumerle L, Klopp N, Trabetti E, et al. 2008. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 3(4):289-99
69. Manev R, Manev H. 2004. 5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders. Crit. Rev. Neurobiol. 16(1-2):181-86 (Pubitemid 39586916)
70. Markovic O, O'Reilly G, Fussell HM, Turner SJ, Calder PC, et al. 2004. Role of single nucleotide polymorphisms of pro-inflammatory cytokine genes in the relationship between serum lipids and inflammatory parameters, and the lipid-lowering effect of fish oil in healthy males. Clin. Nutr. 23(5):1084-95 (Pubitemid 39243024)
71. Martinelli N, Girelli D, Malerba G, Guarini P, Illig T, et al. 2008. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am. J. Clin. Nutr. 88(4):941-49
72. Masugi J, Tamori Y, Mori H, Koike T, Kasuga M. 2000. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Biochem. Biophys. Res. Commun. 268:178-82 (Pubitemid 30116630)
73. Minihane AM. 2010. Fatty acid-genotype interactions and cardiovascular risk. Prostaglandins Leukot. Essent. Fatty Acids 82:259-64
74. Minihane AM, Khan S, Leigh-Firbank EC, Talmud P, Wright JW, et al. 2000. ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler. Thromb. Vasc. Biol. 20:1990-97 (Pubitemid 30648814)
75. Moran O, Phillip M. 2003. Leptin: obesity, diabetes and other peripheral effects-a review. Pediatr. Diabetes 4:101-9 (Pubitemid 36818102)
76. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ. 2000. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation 102:1264-69
77. Nogueiras R, Lopez M, Dieguez C. 2010. Regulation of lipid metabolism by energy availability: a role for the central nervous system. Obes. Rev. 11:185-201
78. Olano-Martin E, Anil E, Caslake MJ, Packard CJ, Bedford D, et al. 2010. Contribution of apolipoprotein E genotype and docosahexaenoic acid to the LDL-cholesterol response to fish oil. Atherosclerosis 209(1):104-10
79. Olivieri O, Martinelli N, Sandri M, Bassi A, Guarini P, et al. 2005. Apolipoprotein C-III, n-3 polyunsaturated fatty acids, and "insulin- resistant" T-455C APOC3 gene polymorphism in heart disease patients: example of gene-diet interaction. Clin. Chem. 51(2):360-67 (Pubitemid 40175806)
80. Phillips CM, Goumidi L, Bertrais S, Ferguson JF, Field MR, et al. 2009. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am. J. Clin. Nutr. 90(6):1665-73
81. Phillips CM, Goumidi L, Bertrais S, FieldMR, Ordovas JM, et al. 2010. Leptin receptor polymorphisms interact with polyunsaturated fatty acids to augment risk of insulin resistance and metabolic syndrome in adults. J. Nutr. 140(2):238-44
82. Pishva H, Mahboob SA, Mehdipour P, Eshraghian MR, Mohammadi-Asl J, et al. 2010. Fatty acidbinding protein-2 genotype influences lipid and lipoprotein response to eicosapentaenoic acid supplementation in hypertriglyceridemic subjects. Nutrition 26(11-12):1117-21
83. Plourde M, Vohl MC, Vandal M, Couture P, Lemieux S, Cunnane SC. 2009. Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE epsilon4 but not by the common PPAR-alpha L162V polymorphism in men. Br. J. Nutr. 102(8):1121-24
84. Poole EM, Hsu L, Xiao L, Kulmacz RJ, Carlson CS, et al. 2010. Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma. Cancer Epidemiol. Biomarkers Prev. 19(2):547-57
85. Psota TL, Gebauer SK, Kris-Etherton P. 2006. Dietary omega-3 fatty acid intake and cardiovascular risk. Am. J. Cardiol. 98:3-18i
86. Pullin CH, Wilson JF, Ashfield-Watt PA, Clark ZE, Whiting JM, et al. 2002. Influence of methylenetetrahydrofolate reductase genotype, exercise and other risk factors on endothelial function in healthy individuals. Clin. Sci. (Lond.) 102(1):45-50 (Pubitemid 34177800)
87. Rimbach G, Minihane AM. 2009. Nutrigenetics and personalised nutrition: How far have we progressed and are we likely to get there? Proc. Nutr. Soc. 68(2):162-72
88. Rudkowska I. 2010. Fish oils for cardiovascular disease: impact on diabetes. Maturitas 67:25-28
89. Rudkowska I, Caron-Dorval D, Verreault M, Couture P, Deshaies Y, et al. 2010. PPARalpha L162V polymorphism alters the potential of n-3 fatty acids to increase lipoprotein lipase activity. Mol. Nutr. Food Res. 54(4):543-50
90. Rudkowska I,GarencC,Couture P, VohlMC. 2009. Omega-3 fatty acids regulate gene expression levels differently in subjects carrying the PPARalpha L162V polymorphism. Genes Nutr. 4(3):199-205
91. Rzehak P, Heinrich J, Klopp N, Schaeffer L, Hoff S, et al. 2009. Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes. Br. J. Nutr. 101:20-26 (Pubitemid 352795577)
92. Sabatti C, Service SK,Hartikainen AL, Pouta A, Ripatti S, et al. 2009. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nat. Genet. 41:35-46
93. Sapone A, Peters JM, Sakai S, Tomita S, Papiha SS, et al. 2000. The human peroxisome proliferatoractivated receptor alpha gene: identification and functional characterization of two natural allelic variants. Pharmacogenetics 10:321-33 (Pubitemid 30345180)
94. Saravanan P, Davidson NC, Schmidt EB, Calder PC. 2010. Cardiovascular effects of marine omega-3 fatty acids. Lancet 376:540-50
95. Scaglioni S, Verduci E, Salvioni M, Biondi ML,Radaelli G, et al. 2006. PPAR-gamma2 Pro12Ala variant, insulin resistance and plasma long-chain polyunsaturated fatty acids in childhood obesity. Pediatr. Res. 60(4):485-89 (Pubitemid 44427605)
96. Schaeffer L, Gohlke H, M̈uller M, Heid IM, Palmer LJ, et al. 2006. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum. Mol. Genet. 15(11):1745-56 (Pubitemid 43821765)
97. Schraut W, Wendelgass P, Calzada-Wack JC, Frankenberger M, Ziegler-Heitbrock HW. 1997. TNF gene expression in monocytes of low and high responder individuals. Cytokine 9(3):206-11 (Pubitemid 27152065)
98. Schwartz D, Kisselev P, Chernogolov A, SchunckWH, Roots I. 2005. Human CYP1A1 variants lead to differential eicosapentaenoic acid metabolite patterns. Biochem. Biophys. Res. Commun. 336:779-83 (Pubitemid 41338336)
99. Sci. Advis. Comm. Nutr. Comm. Toxicity, Food Standards Agency. 2004. Advice on Fish Consumption: Benefits and Risks. Norwich, UK: TSO
100. Shaw D, Hall W, Williams C. 2006. Dietary fatty acids, insulin resistance and diabetes. In Improving the Fat Content of Foods, ed. CWilliams, J Buttriss, Pt. I, 2:25-43. Cambridge, UK: Woodhead Publ.
101. Shen J, Arnett DK, Peacock JM, Parnell LD, Kraja A, et al. 2007. Interleukin1beta genetic polymorphisms interact with polyunsaturated fatty acids to modulate risk of the metabolic syndrome. J. Nutr. 137(8):1846-51 (Pubitemid 47292728)
102. Siersbaek R, Nielsen R, Mandrup S. 2010. PPARgamma in adipocyte differentiation and metabolism-novel insights from genome-wide studies. FEBS Lett. 584:3242-49
103. Siezen CL, Bueno-de-Mesquita HB, Peeters PH, Kram NR, van Doeselaar M, van Kranen HJ. 2006. Polymorphisms in the genes involved in the arachidonic acid-pathway, fish consumption and the risk of colorectal cancer. Int. J. Cancer 119(2):297-303
104. Siezen CL, van Leeuwen AI, Kram NR, Luken ME, van Kranen HJ, Kampman E. 2005. Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption. Carcinogenesis 26(2):449-57 (Pubitemid 40246567)
105. Sirtori CR, Tremoli E, Sirtori M, Conti F, Paoletti R. 1977. Treatment of hypertriglyceridemia with metformin. Effectiveness and analysis of results. Atherosclerosis 26(4):583-92 (Pubitemid 8076499)
106. Sofi F, Fatini C, Sticchi E, Lenti M, Gori AM, et al. 2007. Fish intake and LPA 93C>T polymorphism: gene-environment interaction in modulating lipoprotein (a) concentrations. Atherosclerosis 195(2):e147-54 (Pubitemid 350103702)
107. Sprecher H. 1999. An update on the pathways of polyunsaturated fatty acid metabolism. Curr. Opin. Clin. Nutr. Metab. Care 2(2):135-38 (Pubitemid 129627810)
108. Su KP, Huang SY, Peng CY, Lai HC, Huang CL, et al. 2010. Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels. Biol. Psychiatry 67(6):550-57
109. Tai ES, Corella D, Demissie S, Cupples LA, Coltell O, et al. 2005. Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J. Nutr. 135(3):397-403 (Pubitemid 40365194)
110. Tanaka T, Shen J, Abecasis GR, Kisialiou A, Ordovas JM, et al. 2009. Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study. PLoS Genet. 5(1):e1000338
111. Thies F, Garry JM, Yaqoob P, Rerkasem K, Williams J, et al. 2003. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361:477-85 (Pubitemid 36173713)
112. Tilley SL, Hartney JM, Erikson CJ, Jania C, Nguyen M, et al. 2003. Receptors and pathways mediating the effects of prostaglandin E2 on airway tone. Am. J. Physiol. Lung Cell Mol. Physiol. 284:L599-606 (Pubitemid 36343308)
113. Tontonoz P, Spiegelman BM. 2008. Fat and beyond: the diverse biology of PPARgamma. Annu. Rev. Biochem. 77:289-312
114. Truong H, DiBello JR, Ruiz-Narvaez E, Kraft P, Campos H, Baylin A. 2009. Does genetic variation in the Delta6-desaturase promoter modify the association between alpha-linolenic acid and the prevalence of metabolic syndrome? Am. J. Clin. Nutr. 89(3):920-25
115. Vanschoonbeek K, Feijge MA, PaquayM, Rosing J, Saris W, et al. 2004. Variable hypocoagulant effect of fish oil intake in humans: modulation of fibrinogen level and thrombin generation. Arterioscler. Thromb. Vasc. Biol. 24(9):1734-40 (Pubitemid 39180903)
116. Vanschoonbeek K, Feijge MA, Saris WH, de Maat MP, Heemskerk JW. 2007. Plasma triacylglycerol and coagulation factor concentrations predict the anticoagulant effect of dietary fish oil in overweight subjects. J. Nutr. 137(1):7-13 (Pubitemid 46052851)
117. Verduci E, Scaglioni S, Agostoni C, Radaelli G, Biondi M, et al. 2009. The relationship of insulin resistance with SNP 276G>T at adiponectin gene and plasma long-chain polyunsaturated fatty acids in obese children. Pediatr. Res. 66(3):346-49
118. Volcik KA, Nettleton JA, Ballantyne CM, Boerwinkle E. 2008. Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study. Am. J. Clin. Nutr. 87(6):1926-31 (Pubitemid 351872660)
119. Wang Z, Yin S, Zhao X, Russell RM, Tang G. 2004. beta-Carotene-vitamin A equivalence in Chinese adults assessed by an isotope dilution technique. Br. J. Nutr. 91(1):121-31 (Pubitemid 38100567)
120. Warne JP. 2003. Tumour necrosis factor alpha: a key regulator of adipose tissue mass. J. Endocrinol. 177:351-55 (Pubitemid 36722289)
121. Willer CJ, Speliotes EK, Loos RJ, Li S, Lindgren CM, et al. 2009. Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat. Genet. 41:25-34
122. Williams CM, Ordovas JM, Lairon D, Hesketh J, Lietz G, et al. 2008. The challenges for molecular nutrition research 1: linking genotype to healthy nutrition. Genes Nutr. 3(2):41-49
123. Wittwer J, Hersberger M. 2007. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot. Essent. Fatty Acids 77(2):67-77 (Pubitemid 47539103)
124. Xie L, Innis SM. 2008. Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation. J. Nutr. 38(11):2222-28
125. Ye J. 2008. Regulation of PPARgamma function by TNF-alpha. Biochem. Biophys. Res. Commun. 374:405-8
126. Yl ̈onen SK, Salminen I, Lyssenko V, Virtanen SM, Groop L, et al. 2008. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism. Eur. J. Clin. Nutr. 62(12):1432-39 (Pubitemid 352807338)
127. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, et al. 2007. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients ( JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369:1090-98 (Pubitemid 46483662)
128. Zeman M, Vecka M, J́achymov́a M, Jiŕak R, Tvrzicḱa E, et al. 2009. Fatty acid CoA ligase-4 gene polymorphism influences fatty acid metabolism in metabolic syndrome, but not in depression. Tohoku J. Exp. Med. 217(4):287-93